Systems and methods for continuous manufacturing of liposomal drug formulations

US10632072B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10632072-B2
Application numberUS-201615557575-A
CountryUS
Kind codeB2
Filing dateMar 18, 2016
Priority dateMar 19, 2015
Publication dateApr 28, 2020
Grant dateApr 28, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides systems and methods for the continuous production of liposomes. An example method includes (a) mixing a solution of lipid and organic solvent from one or more containers to create an organic solvent-lipid solution, (b) providing the organic solvent-lipid solution to a first inlet of an injection port at a first flow rate, wherein the first inlet is in fluid communication with a first conduit, (c) providing an aqueous solution to a second inlet of the injection port at a second flow rate, wherein the second inlet is influid communication with a second conduit, wherein the first conduit is positioned concentrically within the second conduit at an outlet of the injection port, and wherein the first conduit extends through the outlet of the injection port, and (d) mixing the organic lipid solution and the aqueous solution to create a plurality of liposomes.

First claim

Opening claim text (preview).

We claim: 1. A system comprising: one or more containers; one or more vessels; an injection port including: a first inlet including a first conduit in fluid communication with the one or more containers, a second inlet including a second conduit in fluid communication with the one or more vessels, and an outlet, wherein the first conduit is positioned concentrically within the second conduit, wherein the first conduit extends through the outlet, wherein the second conduit extends through the outlet, and wherein the first conduit terminates within the second conduit; a three-way port including a first port in fluid communication with the outlet of the injection port, a second port in fluid communication with the one or more vessels, and a third port comprising an outlet port; and one or more degassing units positioned between the injection port and the three-way port. 2. The system of claim 1 , further comprising: a first gear pump positioned between a first vessel of the one or more vessels and the injection port; a second gear pump positioned between a second vessel of the one or more vessels and the three-way port; and a third gear pump positioned between the one or more containers and the injection port. 3. The system of claim 2 , further comprising: a first flow meter positioned between the first gear pump and the injection port; a second flow meter positioned between the second gear pump and the three-way port; and a third flow meter positioned between the third gear pump and the injection port. 4. The system of claim 1 , wherein the injection port, the first conduit and the second conduit each comprise stainless steel. 5. The system of claim 1 , wherein in the injection port, the first conduit extends between about 0.5 inches to about 24 inches from the outlet, and wherein the second conduit extends between about 0.5 inches to about 24 inches from the outlet. 6. The system of claim 1 , further comprising: a mixer positioned between the one or more containers and the injection port. 7. The system of claim 6 , wherein the mixer is a static mixer combines solutions from each of the one or more containers. 8. The system of claim 1 , wherein the second conduit of the injection port is in fluid communication with a first vessel of the one or more vessels, and wherein the second port of the three-way port is in fluid communication with a second vessel of the one or more vessels. 9. The system of claim 1 , wherein the second conduit of the injection port is in fluid communication with a first vessel of the one or more vessels, and wherein the second port of the three-way port is also in fluid communication with the first vessel of the one or more vessels. 10. The system of claim 1 , wherein the system comprises of two or more injection ports, wherein an outlet of each of the two or more injection ports is in fluid communication with the first port of the three-way port. 11. The system of claim 1 , further comprising: a dynamic light scattering particle size analyzer in fluid communication with the third port of the three-way port, wherein the particle size analyzer is configured to determine a size of liposomes; and a controller configured to: determine a difference between a desired size of the liposomes and the determined size of the liposomes; and in response to the determined difference, adjust one or more parameters of the system. 12. The system of claim 11 , wherein the one or more parameters of the system comprises one or more of (i) a flow rate at which an aqueous solution is supplied from the one or more vessels to the second inlet of the injection port, (ii) a flow rate of an organic lipid solution supplied from the one or more containers to the first inlet of the injection port, (iii) a temperature of the aqueous solution supplied from the one or more vessels to the second inlet of the injection port, (iv) a temperature of the organic lipid solution supplied from the one or more containers to the first inlet of the injection port, (v) a lipid concentration of the organic lipid solution supplied from the one or more containers to the first inlet of the injection port, and (vi) a viscosity of the aqueous solution supplied from the one or more vessels to the second inlet of the injection port. 13. A method for the continuous production of liposomes, the method comprising: providing the system of claim 1 ; mixing a solution of lipid and organic solvent from the one or more containers to create an organic solvent-lipid solution; providing the organic solvent-lipid solution to the first inlet of the injection port at a first flow rate, wherein the first inlet is in fluid communication with the first conduit; providing an aqueous solution to the second inlet of the injection port at a second flow rate, wherein the second inlet is in fluid communication with the second conduit, wherein the first conduit is positioned concentrically within the second conduit at the outlet of the injection port, and wherein the first conduit extends through the outlet of the injection port; and mixing the organic lipid solution and the aqueous solution to create a plurality of liposomes. 14. The method of claim 13 , the method further comprising: determining a size of one or more of the plurality of liposomes. 15. The method of claim 14 , wherein the determining is done while the plurality of liposomes move at a constant flow rate. 16. The method of claim 14 , wherein the determining comprises: momentarily stopping a pump to prevent fluid flow of the one or more of the plurality of liposomes; determining the size of one or more of the plurality of liposomes while the plurality of liposomes are at rest; and starting the pump to resume fluid flow. 17. The method of claim 13 , further comprising: determining a difference between a desired size of the one or more liposomes and the determined size of the one or more liposomes; and in response to the determined difference, adjusting at least one of the following parameters: aqueous phase flow rate, organic phase flow rate, lipid concentration, aqueous phase temperature, type of lipid and aqueous phase additives, and organic phase temperature. 18. The method of claim 13 , further comprising: passing the plurality of liposomes to a tangential flow filtration unit; determining a total lipid concentration of the plurality of liposomes; determining a difference between a desired total lipid concentration of the liposomes and the determined total lipid concentration of the liposomes; and in response to the determined difference, adjusting a permeate flow rate of the tangential flow filtration unit and/or adjusting a pressure of the tangential flow filtration unit. 19. The method of claim 13 , further comprising: passing the plurality of liposomes to a degassing unit the one or more degassing units; passing the plurality of liposomes from the degassing unit to the first port of the three-way port; providing an aqueous buffer to the second port of the three-way port at a third flow rate; and mixing the plurality of liposomes and the aqueous buffer.

Assignees

Inventors

Classifications

  • A61K9/1277Primary

    Preparation processes; Proliposomes · CPC title

  • by physical processes, e.g. drying, spraying · CPC title

  • Operations & Transport · mapped topic

  • Operations & Transport · mapped topic

  • Operations & Transport · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10632072B2 cover?
The present disclosure provides systems and methods for the continuous production of liposomes. An example method includes (a) mixing a solution of lipid and organic solvent from one or more containers to create an organic solvent-lipid solution, (b) providing the organic solvent-lipid solution to a first inlet of an injection port at a first flow rate, wherein the first inlet is in fluid commu…
Who is the assignee on this patent?
Univ Connecticut
What technology area does this patent fall under?
Primary CPC classification A61K9/1277. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).